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Summary Environmental scientists are now raising great concern on the impact
of drugs on the environment and microbiologists are concerned about increas-
ing antibiotic resistance due to irrational usage. However, a focus on the impact
by the use of antibiotics (irrational/prescribed) to the environment at therapeu-
tic doses has not been instituted. Even the World Health Organization (WHO)
deﬁned ‘‘Pharmacovigilance’’ activities as the monitoring, detection, assessment,
understanding and prevention of any adverse reactions to drugs at therapeutic con-
centration on animals and humans. Nevertheless, there is little attention being
given to identifying the adverse effects (ADEs) of antimicrobial agents on the
environment (given at therapeutic doses). This issue has been highlighted in the
present commentary and a new domain, ‘‘Pharmaco-EcoMicrobiology’’, has been
proposed which should deal with and monitor such adverse effects. The term
‘‘Pharmaco-EcoMicrobiology’’ has been proposed to deﬁne the interplay between
antimicrobial pharmacological agents and animate microbial ecology. This new
domain, ‘‘Pharmaco-EcoMicrobiology’’, has been derived by the aggregation of three
important branches of science (pharmacology + ecology +microbiology) and would be
responsible for studying the ADEs due to antimicrobial drugs excreted in environ-
ment.
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tFigure 1 Algorithms showing the recent term ‘‘Pharm
impacts to microorganisms and human/animals, and the
multi-drug-resistant infections.
In this article, We propose the term ‘‘Pharmaco-
EcoMicrobiology’’ to deﬁne the interplay between
pharmacological antimicrobial agent and animate
microbial ecology. A detailed algorithm describ-
ing the components of this newer domain and the
adverse drug effects (ADEs) occurring and to be
monitored under this domain is shown in Fig. 1. In
brief, this proposed domain includes medical and
veterinary components through which the metab-
olized and non-metabolized antimicrobial drugs in
human and animal guts, as well as those excreted
in the environment, give rise to the development of
antibiotic resistance in bacteria due to the selec-
tion pressure. These multi-drug resistant (MDR)
organisms are then responsible for giving rise to
MDR infections.
To review possible sources of antibiotics in the
environment, including those mentioned above;
these could be as follows:
(a) Sewage: The antibiotics that we take in are
not all processed by our bodies. Clearly, the
unprocessed drug will pass into the environ-
ment along with feces and urine and ultimately
reside in our wastewater treatment plants. Not
only unprocessed drugs, but also the metabo-
lites with active components excreted through
the same routes.
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terrelationship. MDR infections in above ﬁgure refer to
b) Animal production and veterinary practice:
Antibiotics are commonly added to animal
feeds as growth promoters and also added to
ﬁshery waters. Similarly, antibiotics are given
at therapeutic doses by veterinary doctors to
treat diseases in animals.
(c) Medical waste: The dispensing of antibiotics in
a medical facility inevitably leads to waste.
d) Household products: Many ‘‘antibacterial’’
household products have been introduced in
recent years, including, toothpastes, cements,
paints, etc. with antibacterial ingredients like
triclosan, quaternary ammonium compounds,
alcohol, and bleach. These antimicrobial com-
pounds are eventually disposed of and can
cause an impact on the environment.
e) Crop-sprays: Antibiotics are sprayed on crops
to treat bacterial infections that in turn cause
adverse effects to the environment.
According to the World Health Organization
WHO), ‘‘Pharmacovigilance’’ activities are done
o monitor detection, assessment, understanding
nd prevention of any obnoxious adverse reactions
o drugs at therapeutic concentration on animals
nd humans. However, in recent years, environmen-
al scientists have raised a great concern on the
mpacts of drugs on the environment and surround-
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[harmaco-EcoMicrobiology—a newer domain
ng [1]. To summarize a few noteworthy hazardous
mpacts reported previously, ﬁrst the detection of
rugs in sewage at Big Blue River sewage treatment
lant at Kansas City, Missouri [2], a vulture’s death
fter consumption of animal carcasses treated with
iclofenac sodium [3,4], and feminization of male
sh by ethinyl estradiol [5]. There are also other
eports on disturbed environmental fauna due to
rugs eliminated in environmental surroundings. In
ecent years, microbiologists have raised great con-
erns about increasing antibiotic resistance [6—9]
ocusing much on irrational use. However, a focus
n the impact to the environment by the use
f irrationally prescribed antibiotics at therapeu-
ic doses has not been instituted. Nevertheless,
here should be concern to ﬁnd the adverse effects
f antimicrobial drugs on the environment given
t therapeutic doses. Therefore, it is interest-
ng to note that despite selective pressure and
ncreasing antibiotic resistance in microorganism
obody has addressed for the vigilance of ADEs
ue to antimicrobials prescribed at therapeutic
oses to human beings and animals. One could
rgue that the effect of antimicrobial agents and
heir effect on microorganisms causing direct or
ndirect damage to humans or animals is a com-
onent of environmental microbiology. It should
herefore be emphasized here that ‘‘Environmental
icrobiology’’ only deals with the study of microor-
anisms living in a variety of environments (air,
oil, water, etc.) and their pathogenic relationship
o other organisms including man, and not with
DEs. Similarly it is true for ‘‘Ecopharmacology’’
Ecosystem+Pharmacology) which describes entry
f chemicals or drugs into the environment through
ny route disturbing the balance of ecology as
consequence. If these drugs enter through
iving beings via elimination subsequent to phar-
acotherapy, logically it should be a speciﬁc
omain of ‘‘pharmacology’’ and not of envi-
onmental studies. And when it disturbs the
cosystem, especially in relation to microorgan-
sms, it also includes components of ‘‘ecology’’
nd ‘‘microbiology’’. Hence, we propose this newer
omain of science as ‘‘Pharmaco-EcoMicrobiology’’
pharmacology + ecosystem+microbiology), which
hould govern the aspects discussed above including
he ADEs on microorganisms due to antimicrobial
rugs excreted in the environment at therapeutic
oses.
These suggestions are not clearly deﬁned in theeﬁnition of ‘‘Environmental Microbiology’’ and
‘Ecopharmacology’’. Moreover, there is lack of
uch a term in the existing literature that takes
nto account medical, veterinary, and environmen-
al aspects of very common practices of use, abuse
[3
nd overuse of antimicrobial agents. Therefore,
e suggest that the adverse effects due to the
ischarge of antimicrobial agents in environment
y above-mentioned routes (c—e) could be com-
onent of environmental microbiology, however,
he antimicrobial agents excreted in the environ-
ent after consumption at therapeutic doses could
e a component of ‘‘Pharmaco-EcoMicrobiology’’
nd therefore should be included as a new compo-
ent of pharmacovigilance or a component bridging
harmacovigilance to ecology and environmental
icrobiology.
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